209 related articles for article (PubMed ID: 22484187)
21. Treatment of cutaneous lymphomas: an update.
Izu-Belloso RM; García-Ruiz JC
Actas Dermosifiliogr; 2012 Oct; 103(8):694-707. PubMed ID: 22575363
[TBL] [Abstract][Full Text] [Related]
22. [Development of targeted treatments for cutaneous T cell lymphomas].
Bagot M
Bull Acad Natl Med; 2012 Mar; 196(3):631-40; discussion 640-1, 653-4. PubMed ID: 23472352
[TBL] [Abstract][Full Text] [Related]
23. Refractory, concomitant, cutaneous, and systemic lymphomas of discordant B-cell and T-cell lineages.
Au WY; Lie AK; Lam WW; Chan JK
Am J Dermatopathol; 2010 Feb; 32(1):102-4. PubMed ID: 19915452
[No Abstract] [Full Text] [Related]
24. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab.
Bonnekoh B; Schulz M; Franke I; Gollnick H
J Cancer Res Clin Oncol; 2002 Mar; 128(3):161-6. PubMed ID: 11935303
[TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous follicular helper T-cell lymphoma: diagnostic pitfalls of this new lymphoma subtype.
Buder K; Poppe LM; Bröcker EB; Goebeler M; Rosenwald A; Geissinger E; Kerstan A
J Cutan Pathol; 2013 Oct; 40(10):903-8. PubMed ID: 23941646
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous B-cell lymphoma: important diagnostic tools.
Ferenczi K
G Ital Dermatol Venereol; 2010 Jun; 145(3):361-73. PubMed ID: 20461044
[TBL] [Abstract][Full Text] [Related]
27. [Management of cutaneous T-cell lymphomas: Recommendations of the French Cutaneous Lymphoma Group].
Beylot-Barry M; Dereure O; Vergier B; Barete S; Laroche L; Machet L; Delfau-Larue MH; D'Incan M; Grange F; Ortonne N; Merlio JP; Bagot M;
Ann Dermatol Venereol; 2010 Oct; 137(10):611-21. PubMed ID: 20932440
[TBL] [Abstract][Full Text] [Related]
28. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
Kempf W; Dummer R; Burg G
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
30. Systemic therapy of cutaneous T-cell lymphoma (CTCL).
Alpdogan O; Kartan S; Johnson W; Sokol K; Porcu P
Chin Clin Oncol; 2019 Feb; 8(1):10. PubMed ID: 30818958
[TBL] [Abstract][Full Text] [Related]
31. The optimal use of bexarotene in cutaneous T-cell lymphoma.
Gniadecki R; Assaf C; Bagot M; Dummer R; Duvic M; Knobler R; Ranki A; Schwandt P; Whittaker S
Br J Dermatol; 2007 Sep; 157(3):433-40. PubMed ID: 17553039
[TBL] [Abstract][Full Text] [Related]
32. Update on treatment of cutaneous T-cell lymphoma.
Gardner JM; Evans KG; Musiek A; Rook AH; Kim EJ
Curr Opin Oncol; 2009 Mar; 21(2):131-7. PubMed ID: 19532014
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous B-cell lymphoma: classification and treatment.
Willemze R
Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous pseudolymphomas: classification and differential diagnosis.
Rijlaarsdam JU; Willemze R
Semin Dermatol; 1994 Sep; 13(3):187-96. PubMed ID: 7986687
[TBL] [Abstract][Full Text] [Related]
35. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.
Der-Petrossian M; Valencak J; Jonak C; Klosner G; Dani T; Müllauer L; Pehamberger H; Knobler R; Trautinger F
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):922-7. PubMed ID: 21054571
[TBL] [Abstract][Full Text] [Related]
36. Classification of cutaneous lymphomas.
Burg G; Dummer R; Kerl H
Dermatol Clin; 1994 Apr; 12(2):213-7. PubMed ID: 8045033
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
Whittaker SJ; Foss FM
Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
[TBL] [Abstract][Full Text] [Related]
38. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas.
Starz H; Balda BR; Bachter D; Büchels H; Vogt H
Cancer; 1999 Jan; 85(1):199-207. PubMed ID: 9921993
[TBL] [Abstract][Full Text] [Related]
39. [Cutaneous B-cell lymphoma treatment with rituximab: two cases].
Viguier M; Bachelez H; Brice P; Rivet J; Dubertret L
Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1152-5. PubMed ID: 12442128
[TBL] [Abstract][Full Text] [Related]
40. Staging and management of cutaneous T-cell lymphoma.
Scarisbrick JJ
Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
